Equity Analysis /
United States of America

US : Intercept Pharmaceuticals, Inc. - ICPT | 3Q21 Update: Non-GAAP Profitability as NASH Potentially Re-Emerges

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    3 November 2021
    Published by